Evotec is a drug discovery alliance and development partnership company. It provides pharmaceutical and biotechnology companies, academics, patient advocacy groups, and venture capital firms with drug discovery solutions in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of innovative drug candidates, and consulting arrangements. The company specializes in the areas of neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases, and fibrosis.
|Employees (est.) (Jun 2019)||2,756||(+22%)|
|Share Price (May 2020)||€24.3||(+2%)|
Evotec has 2k Twitter Followers. The number of followers has increased 3.4% month over month
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Evotec founded?
Evotec was founded in 1993.
Who are Evotec key executives?
Evotec's key executives are Werner Lanthaler, Cord Dohrmann and Enno Spillner.
How many employees does Evotec have?
Evotec has 2,756 employees.
Who are Evotec competitors?
Competitors of Evotec include Inovio Pharmaceuticals, Regenxbio and Sangamo BioSciences.
Where is Evotec headquarters?
Evotec headquarters is located at Essener Bogen 7, Hamburg.
Where are Evotec offices?
Evotec has offices in Hamburg, Göttingen, Köln, Planegg and in 8 other locations.
How many offices does Evotec have?
Evotec has 12 offices.
Receive alerts for 300+ data fields across thousands of companies